SCHEMBL19615164

SCHEMBL19615164

[CH2]Oc1ccc(N2CCOCC2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.52
▸ MAPT P10636 9/20 0.52
▸ ALDH1A1 P00352 5/20 0.52
▸ HTT P42858 4/20 0.52
▸ KMT2A Q03164 4/20 0.52
▸ MEN1 O00255 3/20 0.52
▸ RAB9A P51151 3/20 0.52
▸ NPC1 O15118 2/20 0.52
▸ CYP1A2 P05177 1/20 0.52
▸ KDM4E B2RXH2 5/20 0.50
▸ ALOX15 P16050 2/20 0.50
▸ HSD17B10 Q99714 2/20 0.50
▸ USP2 O75604 1/20 0.50
▸ TP53 P04637 1/20 0.50
▸ MAPK1 P28482 1/20 0.50
▸ HPGD P15428 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ AKR1C3 P42330 1/20 0.46
▸ LGMN Q99538 1/20 0.46
▸ TSHR P16473 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9093746 0.82 LMNA (0.71) LMNAMAPTALDH1A1HTTKMT2A
SCHEMBL2208450 0.79 AKR1C3 (0.68) MAPTALDH1A1HTTKMT2AMEN1
SCHEMBL6153218 0.79 LTA4H (0.50) LMNAMAPTALDH1A1KMT2ARAB9A
SCHEMBL27522091 0.79 LMNA (0.52) LMNAMAPTALDH1A1HTTKMT2A
SCHEMBL7882875 0.79 MAPT (0.50) LMNAMAPTALDH1A1HTTKMT2A
SCHEMBL4349056 0.78 AKR1C3 (0.66) LMNAMAPTALDH1A1HTTKMT2A
SCHEMBL5210822 0.78 MAPT (0.50) LMNAMAPTALDH1A1HTTKMT2A
SCHEMBL1825155 0.78 MAPT (0.50) LMNAMAPTALDH1A1HTTKMT2A
SCHEMBL30440657 0.76 LTA4H (0.66) LMNAMAPTALDH1A1HTTKMT2A
SCHEMBL664774 0.76 LMNA (0.58) LMNAMAPTALDH1A1HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3458459-B1 MACROCYCLIC INDOLE DERIVATIVES BAYER AG (DE) 2022-04-27 — — EP claimed
US-10981932-B2 Macrocyclic indole derivatives BAYER AKTIENGESELLSCHAFT (DE) 2021-04-20 — — US claimed
US-20200087322-A1 MACROCYCLIC INDOLE DERIVATIVES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2020-03-19 — — US claimed
EP-3458459-A1 MACROCYCLIC INDOLE DERIVATIVES Bayer Aktiengesellschaft (DE) 2019-03-27 — — EP claimed
WO-2017198341-A1 MACROCYCLIC INDOLE DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 2017-11-23 — — WO claimed
EP-3458459-B1 MACROCYCLIC INDOLE DERIVATIVES BAYER AG (DE) 2022-04-27 — — EP disclosed
US-10981932-B2 Macrocyclic indole derivatives BAYER AKTIENGESELLSCHAFT (DE) 2021-04-20 — — US disclosed
US-20200087322-A1 MACROCYCLIC INDOLE DERIVATIVES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2020-03-19 — — US disclosed
EP-3458459-A1 MACROCYCLIC INDOLE DERIVATIVES Bayer Aktiengesellschaft (DE) 2019-03-27 — — EP disclosed
WO-2017198341-A1 MACROCYCLIC INDOLE DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 2017-11-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10981932-B2 Macrocyclic indole derivatives CCND2, IDO1, CCNT2 LMNA 1055/4885MAPT 2202/4885ALDH1A1 1443/4885
US-20200087322-A1 MACROCYCLIC INDOLE DERIVATIVES CCND2, CCNA1, CCNT2 LMNA 933/4885MAPT 3026/4885ALDH1A1 1379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback